Home › Funds › GUGGENHEIM CAPITAL LLC › GILD

GUGGENHEIM CAPITAL LLC position in GILD

GILEAD SCIENCES INC · Health Care

GUGGENHEIM CAPITAL LLC reported holding 416,657 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$52.6M, representing 0.34% of its reported portfolio and ranking #49 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)416.66K sh
Reported value held$52.64M
Portfolio Weight0.34%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GUGGENHEIM CAPITAL LLC's GILD position evolved

GUGGENHEIM CAPITAL LLC first disclosed a stake in GILD in Q3 2023 at 766,780 shares (US$57.5M). The position peaked in Q4 2025 at 517,789 shares, worth US$63.6M. Across 12 filings, GUGGENHEIM CAPITAL LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 416,657 shares valued at US$52.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 766.78K $57.46M New
Q4 2023 760.40K $61.60M Reduce
Q1 2024 695.90K $50.97M Reduce
Q2 2024 777.91K $53.37M Add
Q3 2024 681.49K $57.14M Reduce
Q4 2024 647.25K $59.79M Reduce
Q1 2025 531.22K $59.52M Reduce
Q2 2025 560.94K $62.19M Add
Q3 2025 528.86K $58.70M Reduce
Q4 2025 517.79K $63.55M Reduce
Q1 2026 416.45K $58.04M Reduce
Q2 2026 416.66K $52.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GUGGENHEIM CAPITAL LLC held GILD?

GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is GUGGENHEIM CAPITAL LLC's current position in GILD?

As of Q2 2026, GUGGENHEIM CAPITAL LLC holds 416.66K shares of GILD (GILEAD SCIENCES INC), valued at $52.64M, representing 0.34% of its reported portfolio and ranking #49.

Has GUGGENHEIM CAPITAL LLC been buying or selling GILD?

In the latest 13F filing (Q2 2026), GUGGENHEIM CAPITAL LLC held unchanged its position in GILD. The position peaked in Q4 2025 at 517.79K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.